[Association between plasma fibrinogen concentration and ten-year change in blood pressure]. 2008

Jun Cheng, and Dong Zhao, and Wei Wang, and Jia-yi Sun, and Yan Li, and Lan-ping Qin, and Zhao-su Wu
Department of Epidemiology, Beijing Anzhen Hospital Affiliated to Capital Medical University & Institute of Beijing Heart, Lung and Blood Vessel Diseases, Beijing 100029, China. wgcj5098@yahoo.com.cn

OBJECTIVE To explore the association between plasma fibrinogen (FIB) concentration and ten-year change in blood pressure in Chinese population aged 35 - 64. METHODS A prospective cohort comprising 2683 subjects was established in Beijing in 1992. Blood pressure (BP) and other traditional cardiovascular risk factors were assessed in 1992 and 2002 respectively, and plasma FIB concentration was measured in 1992. The association of plasma FIB with ten-year change in blood pressure was analyzed. RESULTS (1) The median concentration of FIB among this population was 3.8 g/L (3.2 - 4.3 g/L), and the percentage of the people with abnormal FIB concentration (FIB > 4.0 g/L) was 33.4% in 1992. The FIB concentration of the females was higher than that of the males (P < 0.01) and the FIB concentration of the hypertensive subjects was significantly higher than that of the non-hypertensive subjects (P < 0.05), however, there was no significant difference in the abnormal FIB rate among different age groups. (2) Compared with the BP levels in 1992, the systolic BP and diastolic BP of this population increased by 10.0 mm Hg and 5.0 mm Hg respectively in 2002. The partial correlation coefficients of baseline FIB concentration with ten-year difference for systolic and diastolic BP were 0.125 (P < 0.01) and 0.047 (P < 0.05) respectively, and the absolute value of 10-year increase of systolic pressure in the subjects with abnormal FIB was significantly higher than that in those with normal FIB (P < 0.01). (3) The BP grade 2002 was higher than the baseline grade in 1992 in 49.6% of the study population. The BP grade increase rate of the subjects with abnormal FIB was 55.3%, significantly higher than that of the subjects with normal FIB (46.8%, P < 0.05). (4) In the population without baseline hypertension the risk of BP grade increase within 10 years in those with abnormal FIB was 1.46 times the risk in those with normal FIB, the multivariable OR (95% CI) was 1.457 (1.201 - 1.768) for those with normal BP and 2.082 (1.422 - 3.048) for those with hypertension. CONCLUSIONS Plasma FIB concentration is associated with the BP change. Improvement of high coagulation and high adhesion help control BP, especially in people with hypertension.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D005260 Female Females
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Jun Cheng, and Dong Zhao, and Wei Wang, and Jia-yi Sun, and Yan Li, and Lan-ping Qin, and Zhao-su Wu
January 2019, International journal of endocrinology,
Jun Cheng, and Dong Zhao, and Wei Wang, and Jia-yi Sun, and Yan Li, and Lan-ping Qin, and Zhao-su Wu
September 1995, Blood pressure,
Jun Cheng, and Dong Zhao, and Wei Wang, and Jia-yi Sun, and Yan Li, and Lan-ping Qin, and Zhao-su Wu
January 2014, Clinical and experimental hypertension (New York, N.Y. : 1993),
Jun Cheng, and Dong Zhao, and Wei Wang, and Jia-yi Sun, and Yan Li, and Lan-ping Qin, and Zhao-su Wu
March 1997, Diabetic medicine : a journal of the British Diabetic Association,
Jun Cheng, and Dong Zhao, and Wei Wang, and Jia-yi Sun, and Yan Li, and Lan-ping Qin, and Zhao-su Wu
April 2010, Journal of epidemiology and community health,
Jun Cheng, and Dong Zhao, and Wei Wang, and Jia-yi Sun, and Yan Li, and Lan-ping Qin, and Zhao-su Wu
June 1981, The American journal of medicine,
Jun Cheng, and Dong Zhao, and Wei Wang, and Jia-yi Sun, and Yan Li, and Lan-ping Qin, and Zhao-su Wu
December 1999, Thrombosis research,
Jun Cheng, and Dong Zhao, and Wei Wang, and Jia-yi Sun, and Yan Li, and Lan-ping Qin, and Zhao-su Wu
April 2023, Cureus,
Jun Cheng, and Dong Zhao, and Wei Wang, and Jia-yi Sun, and Yan Li, and Lan-ping Qin, and Zhao-su Wu
August 2002, American journal of industrial medicine,
Jun Cheng, and Dong Zhao, and Wei Wang, and Jia-yi Sun, and Yan Li, and Lan-ping Qin, and Zhao-su Wu
February 1953, Klinische Wochenschrift,
Copied contents to your clipboard!